Bacterin International Revenue and Competitors
Estimated Revenue & Valuation
- Bacterin International's estimated annual revenue is currently $6M per year.
- Bacterin International's estimated revenue per employee is $155,000
Employee Data
- Bacterin International has 39 Employees.
- Bacterin International grew their employee count by 0% last year.
Bacterin International's People
Name | Title | Email/Phone |
---|---|---|
1 | VP RAQA Xtant Medical | Reveal Email/Phone |
2 | Sales Representative | Reveal Email/Phone |
3 | Staff Analyst | Reveal Email/Phone |
4 | Sterilization Team Lead | Reveal Email/Phone |
Bacterin International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 11 | 0% | N/A | N/A |
#2 | $1.9M | 12 | 0% | N/A | N/A |
#3 | $18M | 116 | -6% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $2.3M | 15 | 15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $6M | 39 | 0% | N/A | N/A |
#9 | $2.3M | 15 | -6% | N/A | N/A |
#10 | $5.3M | 34 | 0% | N/A | N/A |
What Is Bacterin International?
Bacterin (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. For more information, please visit http://www.bacterin.com.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.9M | 41 | 0% | N/A |
#2 | $4.5M | 43 | 2% | N/A |
#3 | N/A | 49 | 11% | N/A |
#4 | $12.8M | 50 | -14% | N/A |
#5 | $11.5M | 51 | -29% | N/A |